Sonova stock trades around CHF 230 as dividend outlook supports shares

Published on 09/12/2026 at 14:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova stock closed at CHF 230.80 on SIX Swiss Exchange on September 11, 2026, keeping the hearing-care group near recent highs. A planned dividend increase to CHF 4.80 per share adds support ahead of the next earnings date in November 2026.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti — Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova Holding AG (ISIN CH0012549785) stock traded at CHF 230.80 on SIX Swiss Exchange as of September 11, 2026, leaving the shares close to their recent range after a modest intraday gain of about 0.6 percent versus the prior close of CHF 229.40.

Dividend increase supports Sonova stock

As summarized by Ad-hoc-news on September 10, 2026, Sonova distributed a dividend of CHF 4.70 per share for the 2026 payout and plans to raise the dividend to CHF 4.80 per share for the next distribution, an increase of about 2.1 percent.

According to Ad-hoc-news, the planned dividend increase is framed against Sonova’s most recent full-year results for fiscal year 2025/26, which showed a positive earnings per share trajectory and robust cash generation that management believes can support both higher shareholder returns and continued investment in product development and growth.

Recent price levels and 52-week range

Data from finanzen.ch show that Sonova shares last changed hands at CHF 230.80 on Swiss Exchange at 14:30:30 on September 11, 2026, compared with a prior close of CHF 229.40, representing a gain of around 0.61 percent intraday at that time.

According to a Sonova price overview on finanzen.ch, the stock traded between a day high of CHF 231.20 and a day low of CHF 228.60 on Swiss Exchange on September 11, 2026, on a volume of 10,804 shares, indicating a relatively tight intraday range.

As reported by finanzen.ch on September 11, 2026, Sonova shares reached a 52-week high of CHF 248.00 on August 24, 2026, meaning the closing level of CHF 230.80 on September 11, 2026 left the stock about 6.9 percent below that recent peak.

Full-year 2025/26 performance and outlook

The latest annual report for Sonova, covering fiscal year 2025/26 with a period end in early 2026, is referenced by Ad-hoc-news as the basis for the dividend decision, highlighting that earnings per share continued to grow in fiscal year 2025/26 relative to the prior year.

While the article does not list exact revenue or profit figures, it notes that the combination of EPS growth in fiscal year 2025/26 and the planned dividend increase to CHF 4.80 per share underpins Sonova’s valuation and provides a buffer against potential sector volatility.

For investors, the key narrative is that Sonova is using growing earnings and cash flow from fiscal year 2025/26 to both reward shareholders and maintain investment in innovation, which can be critical in the competitive global hearing-care market.

Analyst and ETF context

In addition to direct coverage of Sonova stock, the company appears as a holding in themed exchange-traded products focused on health technology, which can add an indirect layer of demand from institutional and retail investors following such strategies.

For example, the Langar Global HealthTech ETF lists Sonova, traded as OTCMKT:SONVY, with a holding weight of 3.92 percent in its portfolio as presented on a holdings page updated on September 12, 2026, according to MarketBeat.

This inclusion in a sector-focused ETF means that flows into and out of health technology strategies can influence Sonova’s trading volume and liquidity alongside company-specific news and broader Swiss equity market movements.

Next earnings date and investor focus

The Sonova stock article on Ad-hoc-news cites November 12, 2026 as the next earnings date for Sonova, when investors are expected to receive a fresh update on revenue, margins and earnings for the latest reporting period.

Until then, the planned dividend increase to CHF 4.80 per share and the positive earnings per share development in fiscal year 2025/26 form the main fundamental anchors for Sonova’s share price, alongside its position as a key player in the Swiss hearing-care industry and its presence in health technology investment products.

Sonova stock price as of the last trading day

Sonova stock closed at CHF 230.80 on SIX Swiss Exchange on September 11, 2026, based on Swiss Exchange data, with an intraday gain of about 0.61 percent versus the prior close of CHF 229.40 and a trading range between CHF 228.60 and CHF 231.20 on volume of 10,804 shares.